Clinical Trials Directory

Trials / Conditions / Anti-PD-1 Antibody

Anti-PD-1 Antibody

7 registered clinical trials studyying Anti-PD-1 Antibody — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Su
NCT05771402
The Second Affiliated Hospital of Chongqing Medical UniversityPhase 2
RecruitingA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Su
NCT05769816
The Second Affiliated Hospital of Chongqing Medical UniversityPhase 2
UnknownImmunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial
NCT05290935
Lei LiPhase 2
UnknownAnlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer
NCT04803851
Peking Union Medical College HospitalPhase 1 / Phase 2
UnknownCamrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
NCT04635956
Lei LiPhase 2
RecruitingSintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
NCT04636008
West China HospitalPhase 1 / Phase 2
CompletedImmunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy
NCT04188860
Lei LiPhase 2